Avance Clinical signed a Memorandum of Understanding (MOU) with Taichung Veterans General Hospital (TCVGH), one of Taiwan’s leading medical centers with extensive clinical trial expertise.
Avance Clinical as signed a Memorandum of Understanding (MOU) with Taipei Medical University (TMU), one of Taiwan’s leading medical institutions with extensive clinical trial expertise.
Avance Clinical excited to announce its participation in BIO-Europe Spring 2025, taking place from March 17–19 in Milan, Italy.
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
For early-stage biotech companies, securing funding is often a significant challenge due to the complex and costly nature of drug development.
This event will bring together leading experts in clinical trial management, including our team from Avance Clinical, a full-service CRO specializing in early to late-phase trials for biotech companies across the US, Australia, and Asia.
Join Avance Clinical at AusBiotech 2024 in Melbourne for an opportunity to connect with leading experts in the biotechnology industry.
Avance Clinical, the award-winning market-leading CRO for biotechs, announced today that 2,000 clinical sites across North America had joined the Avance Clinical GlobalReady Site Partnership Network.
Avance Clinical is a full-service Contract Research Organization (CRO) with clinical operations in Australia, New Zealand, Asia, North America, and Europe.
Level 22, 91 King William Street
Adelaide, SA
Australia 5000
Phone: +61 8 8249 4788
For all media enquiries: media@avancecro.com